Multi-center, Single Blinded, RCT, Pivotal Study Efficacy and Safety of DTx to Improve ADHD
This study is completed in South Korea. It focuses on ADHD.
In Seoul
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in South Korea. It focuses on ADHD.
In SeoulThis study is completed. It focuses on mental health and currently lists study information in the United States.
In AlbuquerqueThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In Ann ArborThis study is enrolling by invitation. It focuses on depression and currently lists participation information in the United States.
In JacksonvilleThis study is ongoing in Germany. It is testing neurotransmitters and neuropeptides for schizophrenia.
In GermanyThis study is completed in France. It focuses on schizophrenia.
In MarseilleThis study is completed. It focuses on schizophrenia and currently lists study information in France.
Multiple locations, including DijonThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In FargoThis study is completed. It focuses on schizophrenia and currently lists study information in Oman.
In MuscatThis study is enrolling by invitation. It focuses on anxiety and currently lists participation information in China.
In HangzhouThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In TucsonThis study has public registry information. It focuses on ADHD and currently lists study information in the United States.
In Baltimore